Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Dexamethasone with Local Anaesthetic

Preclinical

UUniversity Of Anbar

Dexamethasone with Local Anaesthetic is one of 2 therapeutic programs targeting Temporomandibular Joint Disorders. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[2][1]

Indication

Temporomandibular Joint DisordersCompleted

Temporomandibular Joint DisordersPreclinical

Completed

Competition

Competitive Landscape

1 competitor in Temporomandibular Joint Disorders

#DrugCompanyPhaseTrials

Botulinum Toxin a

Dexamethasone with Local Anaesthetic

UUniversity Of Anbar

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Temporomandibular Joint Disorders1 trial

Evaluation of the Efficacy of Intra-Articular Injection of Platelet-Rich Plasma Versus Dexamethasone With Local Anaesthetic in the Treatment of Internal Derangement of the Temporomandibular Joint: A Randomised Controlled Trial

Completed·UUniversity Of Anbar·Preclinical·NCT07691684·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dexamethasone with Local Anaesthetic. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Dexamethasone with Local Anaesthetic. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — University Of Anbar company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: UUniversity Of Anbar

Related News